AUPH logo

Aurinia Pharmaceuticals (AUPH) Cash from operations

annual CFO:

$44.39M+$77.85M(+232.66%)
December 31, 2024

Summary

  • As of today (May 24, 2025), AUPH annual cash flow from operations is $44.39 million, with the most recent change of +$77.85 million (+232.66%) on December 31, 2024.
  • During the last 3 years, AUPH annual CFO has risen by +$202.08 million (+128.15%).
  • AUPH annual CFO is now at all-time high.

Performance

AUPH Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

quarterly CFO:

$1.30M-$28.81M(-95.68%)
March 31, 2025

Summary

  • As of today (May 24, 2025), AUPH quarterly cash flow from operations is $1.30 million, with the most recent change of -$28.81 million (-95.68%) on March 31, 2025.
  • Over the past year, AUPH quarterly CFO has increased by +$19.90 million (+106.99%).
  • AUPH quarterly CFO is now -95.68% below its all-time high of $30.11 million, reached on December 31, 2024.

Performance

AUPH quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

TTM CFO:

$64.29M+$19.90M(+44.83%)
March 31, 2025

Summary

  • As of today (May 24, 2025), AUPH TTM cash flow from operations is $64.29 million, with the most recent change of +$19.90 million (+44.83%) on March 31, 2025.
  • Over the past year, AUPH TTM CFO has increased by +$84.67 million (+415.30%).
  • AUPH TTM CFO is now at all-time high.

Performance

AUPH TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AUPH Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+232.7%+107.0%+415.3%
3 y3 years+128.2%+102.8%+142.6%
5 y5 years+169.8%+105.8%+188.0%

AUPH Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+128.2%-95.7%+102.8%at high+142.6%
5 y5-yearat high+128.2%-95.7%+102.4%at high+140.8%
alltimeall timeat high+128.2%-95.7%+102.4%at high+140.8%

AUPH Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.30M(-95.7%)
$64.29M(+44.8%)
Dec 2024
$44.39M(-232.7%)
$30.11M(+76.8%)
$44.39M(+55.3%)
Sep 2024
-
$17.03M(+7.5%)
$28.59M(-1762.0%)
Jun 2024
-
$15.84M(-185.2%)
-$1.72M(-91.6%)
Mar 2024
-
-$18.60M(-229.9%)
-$20.39M(-39.1%)
Dec 2023
-$33.46M(-57.9%)
$14.31M(-207.8%)
-$33.46M(-10.3%)
Sep 2023
-
-$13.28M(+369.8%)
-$37.32M(-5.3%)
Jun 2023
-
-$2.83M(-91.1%)
-$39.41M(-38.9%)
Mar 2023
-
-$31.67M(-403.1%)
-$64.45M(-19.0%)
Dec 2022
-$79.53M(-49.6%)
$10.45M(-168.0%)
-$79.53M(-31.4%)
Sep 2022
-
-$15.36M(-44.9%)
-$115.90M(-17.7%)
Jun 2022
-
-$27.87M(-40.4%)
-$140.79M(-6.7%)
Mar 2022
-
-$46.75M(+80.3%)
-$150.90M(-4.3%)
Dec 2021
-$157.69M(+125.7%)
-$25.92M(-35.6%)
-$157.69M(+22.7%)
Sep 2021
-
-$40.25M(+6.0%)
-$128.57M(+10.1%)
Jun 2021
-
-$37.98M(-29.1%)
-$116.73M(+15.8%)
Mar 2021
-
-$53.54M(-1771.1%)
-$100.79M(+44.3%)
Dec 2020
-$69.86M(+9.9%)
$3.20M(-111.3%)
-$69.86M(-29.1%)
Sep 2020
-
-$28.42M(+28.9%)
-$98.47M(+20.3%)
Jun 2020
-
-$22.04M(-2.5%)
-$81.83M(+12.0%)
Mar 2020
-
-$22.61M(-11.0%)
-$73.04M(+14.9%)
Dec 2019
-$63.59M(+23.2%)
-$25.41M(+115.8%)
-$63.59M(+22.8%)
Sep 2019
-
-$11.78M(-11.2%)
-$51.79M(+0.9%)
Jun 2019
-
-$13.25M(+0.8%)
-$51.34M(+1.9%)
Mar 2019
-
-$13.15M(-3.4%)
-$50.38M(-2.4%)
Dec 2018
-$51.61M(+25.4%)
-$13.62M(+20.2%)
-$51.61M(+10.0%)
Sep 2018
-
-$11.33M(-7.8%)
-$46.93M(+6.4%)
Jun 2018
-
-$12.29M(-14.5%)
-$44.13M(-3.7%)
Mar 2018
-
-$14.38M(+61.0%)
-$45.83M(+11.3%)
Dec 2017
-$41.17M(+120.0%)
-$8.93M(+4.8%)
-$41.17M(+12.8%)
Sep 2017
-
-$8.53M(-39.1%)
-$36.50M(+13.5%)
Jun 2017
-
-$14.00M(+44.1%)
-$32.16M(+38.6%)
Mar 2017
-
-$9.71M(+128.1%)
-$23.21M(+24.0%)
Dec 2016
-$18.71M(+5.3%)
-$4.26M(+1.7%)
-$18.71M(-3.0%)
Sep 2016
-
-$4.19M(-17.0%)
-$19.29M(-5.0%)
Jun 2016
-
-$5.04M(-3.4%)
-$20.31M(+7.1%)
Mar 2016
-
-$5.22M(+7.9%)
-$18.96M(+6.7%)
Dec 2015
-$17.77M(+5.1%)
-$4.84M(-7.1%)
-$17.77M(+9.2%)
Sep 2015
-
-$5.21M(+40.9%)
-$16.28M(+7.9%)
Jun 2015
-
-$3.70M(-8.1%)
-$15.09M(-3.1%)
Mar 2015
-
-$4.02M(+20.1%)
-$15.58M(-7.9%)
Dec 2014
-$16.91M(+266.0%)
-$3.35M(-16.8%)
-$16.91M(+4.9%)
Sep 2014
-
-$4.02M(-3.8%)
-$16.11M(+18.7%)
Jun 2014
-
-$4.18M(-21.9%)
-$13.57M(+38.9%)
Mar 2014
-
-$5.35M(+109.7%)
-$9.77M(+111.5%)
Dec 2013
-$4.62M(-29.4%)
-$2.55M(+71.9%)
-$4.62M(+62.3%)
Sep 2013
-
-$1.49M(+289.8%)
-$2.85M(+9.3%)
Jun 2013
-
-$381.00K(+89.6%)
-$2.60M(-47.2%)
Mar 2013
-
-$201.00K(-74.2%)
-$4.94M(-24.6%)
Dec 2012
-$6.55M(+383.0%)
-$779.00K(-37.3%)
-$6.55M(-6.6%)
Sep 2012
-
-$1.24M(-54.2%)
-$7.01M(+0.4%)
Jun 2012
-
-$2.71M(+49.8%)
-$6.98M(+21.2%)
Mar 2012
-
-$1.81M(+45.8%)
-$5.76M(+324.8%)
DateAnnualQuarterlyTTM
Dec 2011
-$1.36M(-70.4%)
-$1.24M(+2.3%)
-$1.36M(+55.2%)
Sep 2011
-
-$1.21M(-18.7%)
-$873.60K(-28.0%)
Jun 2011
-
-$1.49M(-157.6%)
-$1.21M(+103.1%)
Mar 2011
-
$2.59M(-441.1%)
-$597.50K(-87.0%)
Dec 2010
-$4.58M(-56.2%)
-$759.90K(-51.1%)
-$4.58M(-13.8%)
Sep 2010
-
-$1.55M(+77.3%)
-$5.32M(+0.5%)
Jun 2010
-
-$876.20K(-37.1%)
-$5.29M(-38.8%)
Mar 2010
-
-$1.39M(-6.6%)
-$8.64M(-17.4%)
Dec 2009
-$10.46M(-39.9%)
-$1.49M(-2.1%)
-$10.46M(+0.8%)
Sep 2009
-
-$1.52M(-63.9%)
-$10.37M(-3.8%)
Jun 2009
-
-$4.23M(+31.7%)
-$10.78M(+1.0%)
Mar 2009
-
-$3.21M(+128.0%)
-$10.68M(-38.6%)
Dec 2008
-$17.39M(-38.9%)
-$1.41M(-27.3%)
-$17.39M(-21.7%)
Sep 2008
-
-$1.94M(-53.1%)
-$22.20M(-25.1%)
Jun 2008
-
-$4.13M(-58.4%)
-$29.64M(-8.3%)
Mar 2008
-
-$9.92M(+59.6%)
-$32.33M(+13.6%)
Dec 2007
-$28.46M(+35.3%)
-$6.21M(-33.7%)
-$28.46M(+3.2%)
Sep 2007
-
-$9.37M(+37.4%)
-$27.57M(+21.3%)
Jun 2007
-
-$6.82M(+12.7%)
-$22.72M(+10.4%)
Mar 2007
-
-$6.05M(+13.6%)
-$20.59M(-2.1%)
Dec 2006
-$21.03M(-0.9%)
-$5.32M(+17.6%)
-$21.03M(+0.8%)
Sep 2006
-
-$4.53M(-3.4%)
-$20.87M(+6.0%)
Jun 2006
-
-$4.69M(-27.8%)
-$19.69M(-5.8%)
Mar 2006
-
-$6.49M(+25.8%)
-$20.90M(-1.6%)
Dec 2005
-$21.23M(+5.4%)
-$5.16M(+53.9%)
-$21.23M(-8.9%)
Sep 2005
-
-$3.35M(-43.1%)
-$23.31M(-8.5%)
Jun 2005
-
-$5.89M(-13.6%)
-$25.46M(+6.0%)
Mar 2005
-
-$6.82M(-5.8%)
-$24.02M(+19.2%)
Dec 2004
-$20.15M(+292.5%)
-$7.24M(+31.4%)
-$20.15M(+44.2%)
Sep 2004
-
-$5.51M(+23.8%)
-$13.98M(-5.1%)
Jun 2004
-
-$4.45M(+50.7%)
-$14.73M(+209.4%)
Mar 2004
-
-$2.95M(+176.6%)
-$4.76M(-7.2%)
Dec 2003
-$5.13M(+409.0%)
-$1.07M(-83.0%)
-$5.13M(-33.5%)
Sep 2003
-
-$6.26M(-213.4%)
-$7.72M(-386.6%)
Jun 2003
-
$5.52M(-266.1%)
$2.69M(-213.5%)
Mar 2003
-
-$3.32M(-9.1%)
-$2.37M(+135.4%)
Dec 2002
-$1.01M(-86.1%)
-$3.66M(-188.0%)
-$1.01M(-138.1%)
Sep 2002
-
$4.15M(+816.3%)
$2.65M(-364.4%)
Jun 2002
-
$453.30K(-123.1%)
-$1.00M(-75.6%)
Mar 2002
-
-$1.96M(-488.8%)
-$4.11M(-41.2%)
Dec 2001
-$7.25M(+25.7%)
-
-
Aug 2001
-
$503.80K(-119.0%)
-$6.99M(-21.7%)
May 2001
-
-$2.65M(-6.6%)
-$8.93M(+18.9%)
Feb 2001
-
-$2.84M(+42.5%)
-$7.51M(+30.2%)
Nov 2000
-$5.77M(+324.5%)
-$2.00M(+39.1%)
-$5.77M(+29.3%)
Aug 2000
-
-$1.43M(+16.3%)
-$4.46M(+47.9%)
May 2000
-
-$1.23M(+11.9%)
-$3.02M(+19.3%)
Feb 2000
-
-$1.10M(+60.0%)
-$2.53M(+86.1%)
Nov 1999
-$1.36M(-22.7%)
-$689.10K(-7672.5%)
-$1.36M(+103.0%)
Aug 1999
-
$9100.00(-101.2%)
-$669.10K(-1.3%)
May 1999
-
-$744.50K(-1222.9%)
-$678.20K(-1122.9%)
Feb 1999
-
$66.30K
$66.30K
Nov 1998
-$1.76M
-
-

FAQ

  • What is Aurinia Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual CFO year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly CFO year-on-year change?
  • What is Aurinia Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals TTM CFO year-on-year change?

What is Aurinia Pharmaceuticals annual cash flow from operations?

The current annual CFO of AUPH is $44.39M

What is the all time high annual CFO for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual cash flow from operations is $44.39M

What is Aurinia Pharmaceuticals annual CFO year-on-year change?

Over the past year, AUPH annual cash flow from operations has changed by +$77.85M (+232.66%)

What is Aurinia Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of AUPH is $1.30M

What is the all time high quarterly CFO for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly cash flow from operations is $30.11M

What is Aurinia Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, AUPH quarterly cash flow from operations has changed by +$19.90M (+106.99%)

What is Aurinia Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of AUPH is $64.29M

What is the all time high TTM CFO for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high TTM cash flow from operations is $64.29M

What is Aurinia Pharmaceuticals TTM CFO year-on-year change?

Over the past year, AUPH TTM cash flow from operations has changed by +$84.67M (+415.30%)
On this page